This panel discussion brings together key perspectives on the interplay between heart, metabolic, and renal health, highlighting how SGLT2 inhibitor and DPP-4 inhibitor combinations are reshaping outcomes in patients with diabetes and associated co-morbidities. The session focuses on real-world evidence, patient selection, cardio-renal protection, and practical treatment strategies to achieve comprehensive cardio-renal-metabolic benefits in routine clinical practice.

Hearts, Hormones & Kidneys: Revolutionizing Cardio-Renal-Metabolic Wins with SGLT2i DPP4i combinations

Join our World Heart Day Webinar, where leading 
national cardiologists/cardiovascular health experts will 
share key insights, evidence-based strategies, and emerging 
treatments, and practical interventions to help reduce
the risk of HF & CVD

‘Heart to Heart’ Talks

Chairman, Fortis C-Doc Centre of Excellence for Diabetes and Endocrinology, Chairman National Diabetes, Obesity and Cholesterol Foundation (N.DOC) President, Diabetes Foundation India (DF), New Delhi

Dr. Prof Anoop Misra

2

1.8k

36k

4.7

Sessions Taken

1.4k

4.8

720

4.6